Regulatory preparedness and mitigation strategy for emergency health threats

Abstract

From the past and current experiences, emergency public health threats including coronavirus (COVID-19) are spreading with alarming rate which affects the stability of the global medical products supply chains. For the purposes of this document, the term “emergency health threat” refers to cross border health threats and national health threats in which the government believed and announced to be an emergency threat for the country and means a hazard of biological, chemical, environmental or unknown origin which is likely to spread across the nation and may cause a potential severe risk to public health necessitating a coordinated action at national level. Public health threat is a true test of the global medical products supply chain, and it is urgent that all players including national health regulatory authorities take appropriate steps to improve access to quality assured medical products and protect the safety of patients and the public